Thermo Fisher Scientific Inc. (TMO): Peter E Hornstra , VP & Chief Accounting Officer of Thermo Fisher Scientific Inc. sold 7,811 shares on May 16, 2016. The Insider selling transaction was reported by the company on May 17, 2016 to the Securities and Exchange Commission. The shares were sold at $150.00 per share for a total value of $1,171,650.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Apr 27, 2016, Daniel P Shine (Senior Vice President) sold 6,013 shares at $146.00 per share price.On Apr 7, 2016, Seth H Hoogasian (Sr. VP, Gen. Counsel & Sec.) sold 10,000 shares at $142.05 per share price.Also, On Apr 6, 2016, Patrick M Durbin (Senior Vice President) sold 16,250 shares at $142.18 per share price.On Mar 23, 2016, Stephen Williamson (Sr. VP and CFO) sold 10,708 shares at $139.50 per share price.
Thermo Fisher Scientific: On Monday, May 16, 2016 heightened volatility was witnessed in Thermo Fisher Scientific which led to swings in the share price. The shares opened for trading at $147.9 and hit $150.43 on the upside , eventually ending the session at $150.24, with a gain of 1.59% or 2.35 points. The heightened volatility saw the trading volume jump to 14,73,044 shares. The 52-week high of the share price is $150.43 and the company has a market cap of $59,121 M . The 52-week low of the share price is at $117.1.
Company has been under the radar of several Street Analysts.Thermo Fisher Scientific is Reiterated by Mizuho to Buy and the brokerage firm has raised the Price Target to $ 163 from a previous price target of $160 .The Rating was issued on May 3, 2016.Thermo Fisher Scientific is Downgraded by Jefferies to Hold. Earlier the firm had a rating of Buy on the company shares. The Rating was issued on Apr 29, 2016.Thermo Fisher Scientific is Reiterated by Mizuho to Buy and the brokerage firm has raised the Price Target to $ 160 from a previous price target of $150 .The Rating was issued on Apr 4, 2016.Thermo Fisher Scientific is Reiterated by Topeka Capital Markets to Buy and the brokerage firm has raised the Price Target to $ 155 from a previous price target of $145 .The Rating was issued on Mar 2, 2016.
Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.